Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.415
+0.005 (0.35%)
At close: May 5, 2026, 4:00 PM EDT
1.430
+0.015 (1.06%)
After-hours: May 5, 2026, 4:30 PM EDT
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 119 employees as of December 31, 2025. The number of employees decreased by 83 or -41.09% compared to the previous year.
Employees
119
Change
-83
Growth
-41.09%
Revenue / Employee
$211,849
Profits / Employee
-$738,387
Market Cap
53.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 142 |
| Xilio Therapeutics | 76 |
| PDS Biotechnology | 24 |
| Entera Bio | 22 |
| Instil Bio | 14 |
| Rallybio | 14 |
| Kezar Life Sciences | 9 |
| Hyperion DeFi | 9 |
MGX News
- 19 days ago - Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency - GlobeNewsWire
- 22 days ago - Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 2 months ago - Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Metagenomi Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 4 months ago - Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - GlobeNewsWire
- 5 months ago - Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - GlobeNewsWire
- 5 months ago - Metagenomi Therapeutics Transcript: Jefferies London Healthcare Conference 2025 - Transcripts